A Look at Rx Coverage and Cost in the New Health Insurance Exchanges
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx Coverage and Cost in the New Health Insurance Exchanges,” on May 2 at 4:30 p.m. during the Health Insurance Exchange Summit.
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx Coverage and Cost in the New Health Insurance Exchanges,” on May 2 at 4:30 p.m. during the Health Insurance Exchange Summit.
Dr. Dubois will be joined by Dave Domann, MS, RPh, Director Health Care Quality, Johnson & Johnson Health Care Systems Inc.; Caroline F. Pearson, Director, Avalere Health; and Mark Fendrick, MD, Professor, Department of Internal Medicine & Department of Health Management and Policy, University of Michigan, and Director, University of Michigan Center for Value-Based Insurance Design.
Topics will include variations in drug access across states, access to specialty pharmacy and structured health programs such as value-based insurance design.
The Health Insurance Exchange Summit is being held at the Hyatt Regency Crystal City, 2799 Jefferson Davis Highway, Arlington, VA.